Galida

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2007
01220022007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Tesaglitazar (GALIDA; AstraZeneca, Wilmington, DE) is a dual peroxisome proliferator-activated receptor alpha/gamma agonist… (More)
Is this relevant?
2007
2007
This study examined the effect of tesaglitazar (GALIDA), a dual peroxisome proliferator-activated receptor (PPAR)alpha/gamma… (More)
Is this relevant?
2005
2005
AIMS/HYPOTHESIS Insulin resistance is associated with abnormalities in lipid and glucose metabolism, which are major components… (More)
Is this relevant?
2005
2005
Insulin resistance is associated with abnormalities in lipid and glucose metabolism, which are major components of metabolic… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2004
2004
The pharmacokinetics of tesaglitazar (GALIDA), a novel dual-acting peroxisome proliferator-activated receptor alpha and gamma… (More)
Is this relevant?
2002
2002
In order to know distribution patterns of polychlorinated biphenyl congeners in the marine environment from Galida, PCBs n… (More)
Is this relevant?